Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Dec 12, 2018
Distillery Therapeutics

Neurology

BioCentury | Aug 17, 2018
Targets & Mechanisms

RNA party

Better understanding of non-coding RNAs could open new targets in neurons
BioCentury | Mar 14, 2013
Distillery Therapeutics

Indication: Various

BioCentury | Feb 18, 2013
Clinical News

MiReven, Silence Therapeutics preclinical data

BioCentury | Aug 27, 2012
Finance

Highlights of weekly biotech stock moves

Regulatory, clinical and other milestones
BioCentury | Aug 27, 2012
Company News

MiReven, Silence Therapeutics deal

BioCentury | Aug 23, 2012
Company News

Silence, MiReven in microRNA deal

Items per page:
1 - 7 of 7